O. Ginsburg, F. Bray, and M. P. Coleman, The global burden of women's cancers: a grand challenge in global health, Lancet, vol.389, pp.847-860, 2017.

N. Howlader, S. F. Altekruse, and C. I. Li, US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status, J Natl Cancer Inst, vol.106, pp.1-8, 2014.

C. M. Perou, T. Sørlie, and M. B. Eisen, Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000.

T. O. Nielsen, J. S. Parker, and S. Leung, A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptorpositive breast cancer, Clin Cancer Res, vol.16, pp.5222-5232, 2010.

O. Metzger-filho, Z. Sun, and G. Viale, Patterns of recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX, J Clin Oncol, vol.31, pp.3083-3090, 2013.

M. Colleoni, Z. Sun, and K. N. Price, Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results From the International Breast Cancer Study Group Trials I to V, J Clin Oncol, vol.34, pp.927-935, 2016.

C. X. Ma, R. Bose, and M. J. Ellis, Prognostic and predictive biomarkers of endocrine responsiveness for estrogen receptor positive breast cancer, Adv Exp Med Biol, vol.882, pp.125-154, 2016.

L. E. Dobrolecki, S. D. Airhart, and D. G. Alferez, Patient-derived xenograft (PDX) models in basic and translational breast cancer research, Cancer Metastasis Rev, vol.35, pp.547-573, 2016.

G. Sflomos, V. Dormoy, and T. Metsalu, A preclinical model for ER?-positive breast cancer points to the epithelial microenvironment as determinant of luminal phenotype and hormone response, Cancer Cell, vol.29, pp.407-422, 2016.

E. Richard, T. Grellety, and V. Velasco, The mammary ducts create a favourable microenvironment for xenografting of luminal and molecular apocrine breast tumours, J Pathol, vol.240, pp.256-261, 2016.

S. Lakhani, I. Ellis, and S. Schnitt, WHO Classification of Tumours of the Breast, 2012.

T. Oyama, H. Maluf, and F. Koerner, Atypical cystic lobules: an early stage in the formation of lowgrade ductal carcinoma in situ, Virchows Arch Int J Pathol, vol.435, pp.413-421, 1999.

J. G. Azzopardi, Benign and malignant proliferative epithelial lesions of the breast; a review, Eur J Cancer Clin Oncol, vol.19, pp.1717-1720, 1983.

E. Brogi, T. Oyama, and F. C. Koerner, Atypical cystic lobules in patients with lobular neoplasia, Int J Surg Pathol, vol.9, pp.201-206, 2001.

A. Powe, D. G. Hodi, and Z. , High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma, Am J Surg Pathol, vol.31, pp.417-426, 2007.

G. Curigliano, H. J. Burstein, and E. P. Winer, De-escalating and escalating treatments for early-stage breast cancer: the St, Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer, 2017.

A. Bombonati and D. C. Sgroi, The molecular pathology of breast cancer progression, J Pathol, vol.223, pp.307-317, 2011.